NewslettersHuman Immunology NewsMammary Cell News Immunotherapy in Triple Negative Breast Cancer: Beyond Checkpoint Inhibitors By lbeveridge - November 17, 2022 0 The authors highlight current data and ongoing efforts to establish the safety and efficacy of immunotherapeutic approaches beyond checkpoint inhibitors in TNBC. [npj Breast Cancer] Full Article